284 related articles for article (PubMed ID: 14499440)
1. Impact of CYP2D6 genotype on postoperative tramadol analgesia.
Stamer UM; Lehnen K; Höthker F; Bayerer B; Wolf S; Hoeft A; Stuber F
Pain; 2003 Sep; 105(1-2):231-8. PubMed ID: 14499440
[TBL] [Abstract][Full Text] [Related]
2. Effect of the CYP2D6*10 C188T polymorphism on postoperative tramadol analgesia in a Chinese population.
Wang G; Zhang H; He F; Fang X
Eur J Clin Pharmacol; 2006 Nov; 62(11):927-31. PubMed ID: 16960721
[TBL] [Abstract][Full Text] [Related]
3. Effect of the CYP2D6 gene polymorphism on postoperative analgesia of tramadol in Han nationality nephrectomy patients.
Dong H; Lu SJ; Zhang R; Liu DD; Zhang YZ; Song CY
Eur J Clin Pharmacol; 2015 Jun; 71(6):681-686. PubMed ID: 25948472
[TBL] [Abstract][Full Text] [Related]
4. [Postoperative analgesia with tramadol and metamizol. Continual infusion versus patient controlled analgesia].
Stamer UM; Höthker F; Lehnen K; Stüber F
Anaesthesist; 2003 Jan; 52(1):33-41. PubMed ID: 12577163
[TBL] [Abstract][Full Text] [Related]
5. Tramadol efficacy in patients with postoperative pain in relation to CYP2D6 and MDR1 polymorphisms.
Slanar O; Dupal P; Matouskova O; Vondrackova H; Pafko P; Perlik F
Bratisl Lek Listy; 2012; 113(3):152-5. PubMed ID: 22428763
[TBL] [Abstract][Full Text] [Related]
6. Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption.
Stamer UM; Musshoff F; Stüber F; Brockmöller J; Steffens M; Tzvetkov MV
Pain; 2016 Nov; 157(11):2467-2475. PubMed ID: 27541716
[TBL] [Abstract][Full Text] [Related]
7. Concentrations of tramadol and O-desmethyltramadol enantiomers in different CYP2D6 genotypes.
Stamer UM; Musshoff F; Kobilay M; Madea B; Hoeft A; Stuber F
Clin Pharmacol Ther; 2007 Jul; 82(1):41-7. PubMed ID: 17361124
[TBL] [Abstract][Full Text] [Related]
8. Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
Gan SH; Ismail R; Wan Adnan WA; Zulmi W
Mol Diagn Ther; 2007; 11(3):171-81. PubMed ID: 17570739
[TBL] [Abstract][Full Text] [Related]
9. Role of CYP2D6 Polymorphisms in the Outcome of Postoperative Pain Treatment.
Seripa D; Latina P; Fontana A; Gravina C; Lattanzi M; Savino M; Gallo AP; Melchionda G; Santini SA; Margaglione M; Copetti M; di Mauro L; Panza F; Greco A; Pilotto A
Pain Med; 2015 Oct; 16(10):2012-23. PubMed ID: 25989235
[TBL] [Abstract][Full Text] [Related]
10. CYP2D6*2 Polymorphism as a Predictor of Failed Outpatient Tramadol Therapy in Postherpetic Neuralgia Patients.
Nasare NV; Banerjee BD; Suryakantrao Deshmukh P; Mediratta PK; Saxena AK; Ahmed RS; Bhattacharya SN
Am J Ther; 2016; 23(3):e697-707. PubMed ID: 23567787
[TBL] [Abstract][Full Text] [Related]
11. Impact of the CYP2D6 genotype on post-operative intravenous oxycodone analgesia.
Zwisler ST; Enggaard TP; Mikkelsen S; Brosen K; Sindrup SH
Acta Anaesthesiol Scand; 2010 Feb; 54(2):232-40. PubMed ID: 19719813
[TBL] [Abstract][Full Text] [Related]
12. CYP2D6 polymorphisms and codeine analgesia in postpartum pain management: a pilot study.
VanderVaart S; Berger H; Sistonen J; Madadi P; Matok I; Gijsen VM; de Wildt SN; Taddio A; Ross CJ; Carleton BC; Hayden MR; Koren G
Ther Drug Monit; 2011 Aug; 33(4):425-32. PubMed ID: 21743374
[TBL] [Abstract][Full Text] [Related]
13. Effect of the cytochrome P450 2D6*10 genotype on the pharmacokinetics of tramadol in post-operative patients.
Xu J; Zhang XC; Lv XQ; Xu YY; Wang GX; Jiang B; Cai L; Cai XJ
Pharmazie; 2014 Feb; 69(2):138-41. PubMed ID: 24640604
[TBL] [Abstract][Full Text] [Related]
14. CYP2D6 genotype dependent oxycodone metabolism in postoperative patients.
Stamer UM; Zhang L; Book M; Lehmann LE; Stuber F; Musshoff F
PLoS One; 2013; 8(3):e60239. PubMed ID: 23555934
[TBL] [Abstract][Full Text] [Related]
15. A case of respiratory depression in a child with ultrarapid CYP2D6 metabolism after tramadol.
Orliaguet G; Hamza J; Couloigner V; Denoyelle F; Loriot MA; Broly F; Garabedian EN
Pediatrics; 2015 Mar; 135(3):e753-5. PubMed ID: 25647677
[TBL] [Abstract][Full Text] [Related]
16. Influence of Cytochrome P450, Family 2, Subfamily D, Polypeptide 6 (CYP2D6) polymorphisms on pain sensitivity and clinical response to weak opioid analgesics.
Zahari Z; Ismail R
Drug Metab Pharmacokinet; 2014; 29(1):29-43. PubMed ID: 23759977
[TBL] [Abstract][Full Text] [Related]
17. The effect of
Muradian AA; Sychev DA; Blagovestnov DA; Sozaeva ZA; Akmalova KA; Zastrozhin MS; Kerimova LN; Koroshvili VT; Epifanova IA
Drug Metab Pers Ther; 2021 Jul; 37(1):27-34. PubMed ID: 35385894
[TBL] [Abstract][Full Text] [Related]
18. Antagonistic effects of ondansetron and tramadol? A randomized placebo and active drug controlled study.
Rauers NI; Stüber F; Lee EH; Musshoff F; Fimmers R; Barann M; Stamer UM
J Pain; 2010 Dec; 11(12):1274-81. PubMed ID: 20488759
[TBL] [Abstract][Full Text] [Related]
19. [Chronic dizziness in a pain patient--pharmacogenomic identification of tramadol as cause].
Eichhorn A; Barth J
Rehabilitation (Stuttg); 2010 Dec; 49(6):393-5. PubMed ID: 21140323
[TBL] [Abstract][Full Text] [Related]
20. Decreased Analgesic Effect of Tramadol in Japanese Patients with CYP2D6 Intermediate Metabolizers after Orthopedic Surgery.
Kamiya T; Hira D; Nakajima R; Shinoda K; Motomochi A; Morikochi A; Ikeda Y; Isono T; Akabane M; Ueshima S; Kakumoto M; Imai S; Morita SY; Terada T
Biol Pharm Bull; 2023; 46(7):907-913. PubMed ID: 37394642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
